Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 7:47 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2113–2136 of 18,278 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Controlled Group Clear all

Conditions: Urinary Tract Infections
Interventions: Standard of Care, Experimental; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 664 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 2
States / cities: Madison, Wisconsin

Conditions: Multiple Sclerosis, Cognitive Impairment
Interventions: non-invasive transcranial electrical stimulation; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cystic Fibrosis
Interventions: 7% Hypertonic Saline (HS), 0.9% Isotonic Saline (IS); Drug
Lead sponsor: University of Washington, the Collaborative Health Studies Coordinating Center; Other
Eligibility: 3 Years to 5 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 23
States / cities: Birmingham, Alabama • Palo Alto, California • Aurora, Colorado + 20 more

Conditions: Obese
Interventions: Standard PEEP (8 cmH₂O); Procedure
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Angina Pectoris
Interventions: Ad5FGF-4, Placebo; Genetic
Lead sponsor: Cardium Therapeutics; Industry
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2007
U.S. locations: 47
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 44 more

Conditions: Denture Retention
Interventions: Test Product, Positive Contol, Negative Control; Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Pulmonary Disease, Chronic Obstructive, Asthma
Interventions: BI 1744CL; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 40 Years and older
Enrollment: 409 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2007
U.S. locations: 22
States / cities: Birmingham, Alabama • Lakewood, California • Denver, Colorado + 17 more

Conditions: Multiple Sclerosis
Interventions: CDP323, placebo; Drug
Lead sponsor: UCB Pharma; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 22
States / cities: Cullman, Alabama • Phoenix, Arizona • Tucson, Arizona + 19 more

Conditions: Mild Cognitive Impairment, Subjective Memory Impairment
Interventions: fatty acid/flavonoid blend, Placebo; Dietary Supplement
Lead sponsor: University of East Anglia; Other
Eligibility: 55 Years and older
Enrollment: 259 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Cognitive Development, Emotional Development
Interventions: Parenting Education, Control Group - Safety Materials; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 18 Years to 23 Years · Female only
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Deep Venous Thrombosis
Interventions: Thrombolysis/Thrombectomy; Other
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Postpartum Hemorrhage, Pain
Interventions: Procare abdominal binder, Standard of Care; Device · Other
Lead sponsor: Zachary Kuhlmann, DO; Other
Eligibility: 18 Years to 39 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Wichita, Kansas

Conditions: Overweight and Obesity
Interventions: Behavioral weight loss intervention; Behavioral
Lead sponsor: Drexel University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Aerosol Containment, Aerosol Generating Procedure
Interventions: Novel isolation device to contain aerosol; Device
Lead sponsor: John Shin; Other
Eligibility: 18 Years and older
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Neurofibromatoses
Interventions: Part 1 Levulan injection, Part 1 Levulan surface application, Part 1 Levulan surface application twice, Part 1 Levulan surface application twice with microneedling, Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 1, Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 2, Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 3; Drug
Lead sponsor: Harry T Whelan, MD; Other
Eligibility: 18 Years to 90 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Vitiligo
Interventions: Control Intervention (UVB), Investigational Interventions (Ablative Laser Resurfacing + RECELL + UVB); Device
Lead sponsor: Avita Medical; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 12
States / cities: Irvine, California • Sacramento, California • San Diego, California + 9 more

Conditions: Gut -Microbiota, Inflammatory Markers, Infant Development
Interventions: Infant walnut intake; Other
Lead sponsor: Colorado State University; Other
Eligibility: 5 Months to 5 Months
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Fort Collins, Colorado

Conditions: Fracture
Interventions: Vitamin D3, Placebo; Drug · Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 50 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Thromboembolism, Hemolysis, Stroke
Interventions: Lavare On, Lavare Off; Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 4
States / cities: Birmingham, Alabama • Oak Lawn, Illinois • Indianapolis, Indiana + 1 more

Conditions: Diabetes Mellitus, Type 2 Diabetes, Obesity
Interventions: WW Intervention, Usual Care; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 69 Years
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 3
States / cities: Stanford, California • Baton Rouge, Louisiana • Winston-Salem, North Carolina

Conditions: Hypertension
Interventions: Real PPL, Sim PPL; Behavioral
Lead sponsor: HealthPartners Institute; Other
Eligibility: 22 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Prostate Cancer
Interventions: Amount of Pneumoperitoneum Pressure applied during RARP; Procedure
Lead sponsor: Metro Health, Michigan; Other
Eligibility: 40 Years and older · Male only
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Wyoming, Michigan

Conditions: Healthy Volunteers
Interventions: Vortioxetine, Paroxetine, Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 40 Years
Enrollment: 361 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 15
States / cities: Encino, California • Long Beach, California • Torrance, California + 12 more

Conditions: Decision Making, Video Decision Aids
Interventions: video decision aid; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 60 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

The Utility of Urinalysis Prior to In-Office Procedures

Non-invasive Transcranial Electrical Stimulation in MS

Saline Hypertonic in Preschoolers

Mechanical Ventilation in Obese Surgical Patients

Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization

A Clinical Bite Force Study of Two Marketed Adhesives Against no Adhesive

Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.

Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323

The Cognitive Ageing Nutrition and Neurogenesis (CANN) Trial

Promoting Optimal Parenting (Bright Start)

Second Line Endovascular Treatment in Acute DVT

Do Elastic Abdominal Binders Reduce Post Operative Pain and Blood Loss?

Behavioral Treatment for Weight Loss

An Isolation Device to Contain Aerosol During Aerosol Generating Procedures in the Operating Room

Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)

Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

Walnuts as an Infant Solid Food for Health

Optimal Vitamin D3 Supplementation Strategies for Acute Fracture Healing

Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device

Improving Glycemic Control Using a Virtual Weight Control Program and Continuous Glucose Monitoring

Personalized Physician Learning to Improve Hypertension Care

The Impact of Low Pressure Pneumo in RARP

Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy Volunteers

A Prospective Randomized Trial Using Video Images in Advance Care Planning in Seriously Ill Hospitalized Patients